财务
- Market Capitalization 132.8 B
- Employee 6 400
- Founded 1989
- CEO Reshma Kewalramani
- Website www.vrtx.com
- Headquarter Massachusetts, United States
- FIGI BBG000C1S2X2
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
29.59
市销率
9.75
相关股票代码
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 199 | REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 805.02 USD | -1.72% | +1.57% | +0.14% | +38.68% | 82.88 B USD | ||
| 210 | MRNA Moderna, Inc. - Common Stock | 200.10 USD | -1.25% | -7.90% | +2.43% | +640.56% | 79.89 B USD | ||
| 299 | ARGX argenx SE - American Depositary Shares | 873.71 USD | -0.23% | +7.17% | -9.48% | +5.97% | 54.07 B USD | ||
| 371 | RVMD Revolution Medicines, Inc. - Common Stock | 186.99 USD | -0.37% | +3.98% | -6.74% | +237.53% | 40.08 B USD |